Tanushri Dargar

Dr. Tanushri Dargar

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
FGFabrice Gonnot
Fabrice Gonnot
LBLaura Boulogne
Laura Boulogne
CBCamille Brun
Camille Brun
MDMaya Dia
Maya Dia
YGYves Gouriou
Yves Gouriou
LGLudovic Gomez
Ludovic Gomez
Despite advances in cardioprotection, new therapeutic strategies capable of preventing ischemia-reperfusion injury of patients are still needed. Here, we discover that sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA2) phosphorylation at serine 663 is a clinical and pathophysiological event of cardiac function. Indeed, the phosphorylation level of SERCA2 at serine 663 is increased in ischemic hearts of patients and mouse. Analyses on different human cell lines indicate that preventing serine 663 phosphorylation significantly increases SERCA2 activity and protects against cell death, by counteracting cytosolic and mitochondrial Ca2+ overload. By identifying the phosphorylation level of SERCA2 at serine 663 as an essential regulator of SERCA2 activity, Ca2+ homeostasis and infarct size, these data contribute to a more comprehensive understanding of the excitation/contraction coupling of cardiomyocytes and establish the pathophysiological role and the therapeutic potential of SERCA2 modulation in acute myocardial infarction, based on the hotspot phosphorylation level of SERCA2 at serine 663 residue.

26 July 2023 in EMBO Molecular Medicine
Verified
Journal Article
Open access
ABAnushree Bharadwaj
Anushree Bharadwaj
JSJaydeep Sharma
Jaydeep Sharma
JSJagriti Singh
Jagriti Singh
MKMahima Kumari
Mahima Kumari
TDTanushri Dargar
Tanushri Dargar
SMSam J Mathew
Sam J Mathew
Mutations in MYH3 , the gene encoding the developmental myosin heavy chain‐embryonic (MyHC‐embryonic) skeletal muscle‐specific contractile protein, cause several congenital contracture syndromes. Among these, recessive loss‐of‐function MYH3 mutations lead to spondylocarpotarsal synostosis (SCTS), characterized by vertebral fusions and scoliosis. We find that Myh3 germline knockout adult mice display SCTS phenotypes such as scoliosis and vertebral fusion, in addition to reduced body weight, muscle weight, myofiber size, and grip strength. Myh3 knockout mice also exhibit changes in muscle fiber type, altered satellite cell numbers and increased muscle fibrosis. A mass spectrometric analysis of embryonic skeletal muscle from Myh3 knockouts identified integrin signaling and cytoskeletal regulation as the most affected pathways. These pathways are closely connected to the mechanosensing Yes‐associated protein (YAP) transcriptional regulator, which we found to be significantly activated in the skeletal muscle of Myh3 knockout mice. To test whether increased YAP signaling might underlie the musculoskeletal defects in Myh3 knockout mice, we treated these mice with CA3, a small molecule inhibitor of YAP signaling. This led to increased muscle fiber size, rescue of most muscle fiber type alterations, normalization of the satellite cell marker Pax7 levels, increased grip strength, reduced fibrosis, and decline in scoliosis in Myh3 knockout mice. Thus, increased YAP activation underlies the musculoskeletal defects seen in Myh3 knockout mice, indicating its significance as a key pathway to target in SCTS and other MYH3 ‐related congenital syndromes.

13 December 2023 in Bioengineering
Verified
Journal Article
Open access
PDF file
LLLucas Lemarié
Lucas Lemarié
TDTanushri Dargar
Tanushri Dargar
IGIsabelle Grosjean
Isabelle Grosjean
VGVincent Gache
Vincent Gache
ECEdwin Courtial
Edwin Courtial
JSJérôme Sohier
Jérôme Sohier
Stem cells, particularly human iPSCs, constitute a powerful tool for tissue engineering, notably through spheroid and organoid models. While the sensitivity of stem cells to the viscoelastic properties of their direct microenvironment is well-described, stem cell differentiation still relies on biochemical factors. Our aim is to investigate the role of the viscoelastic properties of hiPSC spheroids’ direct environment on their fate. To ensure that cell growth is driven only by mechanical interaction, bioprintable alginate–gelatin hydrogels with significantly different viscoelastic properties were utilized in differentiation factor-free culture medium. Alginate–gelatin hydrogels of varying concentrations were developed to provide 3D environments of significantly different mechanical properties, ranging from 1 to 100 kPa, while allowing printability. hiPSC spheroids from two different cell lines were prepared by aggregation (⌀ = 100 µm, n > 1 × 104), included and cultured in the different hydrogels for 14 days. While spheroids within dense hydrogels exhibited limited growth, irrespective of formulation, porous hydrogels prepared with a liquid–liquid emulsion method displayed significant variations of spheroid morphology and growth as a function of hydrogel mechanical properties. Transversal culture (adjacent spheroids-laden alginate–gelatin hydrogels) clearly confirmed the separate effect of each hydrogel environment on hiPSC spheroid behavior. This study is the first to demonstrate that a mechanically modulated microenvironment induces diverse hiPSC spheroid behavior without the influence of other factors. It allows one to envision the combination of multiple formulations to create a complex object, where the fate of hiPSCs will be independently controlled by their direct microenvironment.

11 February 2026 in Genes
Verified
Journal Article
Open access
PDF file
TDTanushri Dargar
Tanushri Dargar
AJAlexandre Janin
Alexandre Janin
VRValerie Risson
Valerie Risson
ELEstèle Lafont
Estèle Lafont
CVCamille Valla
Camille Valla
MAMarie Abitbol
Marie Abitbol
Background/Objectives: Human induced pluripotent stem cell (hiPSC) models provide a unique platform for testing the effect of genomic variants identified in patients with inherited diseases. In Alström syndrome, a rare multisystem disorder mainly caused by nonsense mutations in the ALMS1 gene, patients often present with infantile cardiomyopathy, retinal dystrophy, type 2 diabetes, and hearing loss in addition to obesity. These diverse clinical manifestations highlight the pleiotropic functions of ALMS1 in cellular processes such as ciliary signalling, cell cycle regulation, and tissue homeostasis. In cats, the ALMS1:c.7384G>C missense variant has been associated with cardiomyopathy in the absence of other symptoms of Alström syndrome, raising questions regarding the impact of this variant on cardiac pathology. Methods: To answer these questions, we generated an hiPSC line carrying the human ALMS1:c.10004G>C missense variant, homologous to the ALMS1:c.7384G>C feline variant, as well as an isogenic control, to investigate the impact of this variant on cardiomyocyte differentiation and function. Results: The introduction of the ALMS1:c.10004G>C variant in the homozygous state in hiPSCs resulted in a significant reduction in cardiomyocyte differentiation efficiency. However, the variant did not affect contractile frequency, sarcomere organisation, sarcomere length, or cardiomyocyte cell size. Together, these results suggest that while the ALMS1:c.10004G>C variant impairs cardiomyocyte differentiation, it does not disrupt the structural or functional properties of the hiPSC-derived cardiomyocytes that do form. Conclusions: We have generated and initiated the characterisation of the third ALMS1 mutant hiPSC line and the first line based on a missense variant, but further research is needed on its relevance in modelling ALMS1-related changes. Our results also support the previous recommendation not to use ALMS1:c.7384G>C for the selection of breeding cats until further data confirm its intrinsic pathogenicity.

9 April 2026
Verified
Thesis
Closed access
TDTanushri Dargar
Tanushri Dargar
Mécanismes cellulaires conduisant aux myocardiopathies héréditaires : modélisation de deux variants de la lamine A/C et d'ALMS1 dans des cardiomyocytes dérivés d'iPSC humaines: Les myocardiopathies héréditaires sont une cause majeure d'insuffisance cardiaque et de transplantation cardiaque chez l'Homme, résultant de diverses variants génétiques qui compromettent l'homéostasie cellulaire. Mon projet de thèse visait à étudier deux mutations rares affectant la lamine A/C et la protéine ALMS1 associée au syndrome d'Alstrom : LMNA p.L92F et ALMS1 p.G3334R, en utilisant des cardiomyocytes dérivés de cellules souches pluripotentes induites humaines (hiPSC) pour analyser leurs conséquences moléculaires et cellulaires. La mutation LMNA p.L92F, située dans la lamine A/C, a été étudiée dans des cardiomyocytes hiPSC dérivés de deux patients. Les cellules mutantes présentaient des noyaux hypertrophiés et déformés, une instabilité de l'enveloppe nucléaire et une agrégation de la lamine A/C. Ces défauts architecturaux s'accompagnaient d'une accumulation nucléaire accrue de YAP1, indiquant une altération de la mécano-transduction. Sur le plan fonctionnel, les cardiomyocytes mutants présentaient une perturbation de l'homéostasie du calcium ainsi qu'une altération de la respiration mitochondriale. Ces résultats ont mis en lumière que des défauts structurels de l'enveloppe nucléaire pouvaient conduire à une altération de la signalisation intracellulaire, du couplage excitation-contraction et du métabolisme, fournissant ainsi un aperçu mécanistique de la pathogenèse de la myocardiopathie dilatée associée aux mutations de LMNA. En parallèle, le variant ALMS1 p.G3334R, homologue humain d'un variant associé à une myocardiopathie féline, a été modélisé à l'aide de lignées hiPSC isogéniques éditées par CRISPR-Cas9. Les cellules mutantes ont montré une réduction significative de l'efficacité de la différenciation des cardiomyocytes ce qui a suggéré une vulnérabilité précoce lors de la différenciation ou de la survie de la lignée cardiaque. Cependant, les cardiomyocytes qui étaient différenciés présentaient une morphologie, une activité contractile, une structure sarcomérique et un état de nucléation normaux. Ces résultats ont suggéré que le variant p.G3334R agissait probablement comme un allèle modificateur, avec un effet modéré et spécifique de stade de développement des cellules qui influençait l'efficacité de différenciation, sans perturber les propriétés structurelles ou fonctionnelles des cardiomyocytes matures, dans nos conditions expérimentales. Ainsi, nos travaux ont mis en lumière deux voies cellulaires distinctes : la mécano-transduction associée à la structure nucléaire pour le variant de la lamine A/C et la biologie centrosomale et ciliaire pour le variant de ALMS1, impliquées dans la biologie des cardiomyocytes. En intégrant des analyses structurelles, de signalisation et fonctionnelles, nous espérons avoir contribué à la compréhension des mécanismes cellulaires conduisant aux myocardiopathie. Nous avons également confirmé l'intérêt des modèles cellulaires basés sur les hiPSC pour mettre en évidence l'effet de variants génétiques identifiés dans des patients ou des modèles animaux de grande taille, dans les maladies cardiaques.